Basic Ordering Agreement N0018925GZ079

Award Date 5/1/25
Last Date to Order 4/30/35
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
Naval Supply Systems Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is an Indefinite Delivery Contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the University of Oklahoma (OU). The contract vehicle is titled "Preclinical Agent Development Assays 2012-2016" and has a ceiling value of $9,900,000. Under this IDIQ contract, OU has been issued multiple delivery orders totaling over $4.8 million to conduct preclinical research and development...
The Basic Ordering Agreement (BOA) was awarded by the Bureau of Medicine and Surgery, a Defense agency, to Oregon Health & Science University (OHSU), a state-controlled institution of higher learning. The contract has no set-aside designation and is a single award with a ceiling value of $0.00, indicating it is likely a master agreement used to issue future task orders rather than a specific procurement. The BOA aims to provide the agency with specialized medical research, clinical services,...
The University of Iowa has been awarded a Basic Ordering Agreement (BOA) contract by the U.S. Navy Bureau of Medicine and Surgery, a Defense agency. This single-award IDV contract has an ultimate completion date of February 28, 2035, but no specified ceiling value. Under this BOA, the University of Iowa will provide a diverse range of research, healthcare, and specialized services to support critical government missions. This may include laboratory testing services, clinical research support,...
The U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network (VISN) 19, has awarded a Blanket Purchase Agreement (BPA) to OU Medicine Inc., doing business as OU Medical Center, a non-profit hospital in Oklahoma City, Oklahoma. The BPA, valued at a ceiling of $350,000.00, is for the provision of urgent and stat reference laboratory testing services to the Oklahoma City VA. The contract is a single-award, firm-fixed-price BPA with no set-aside designation. To date, two task...
This Basic Ordering Agreement (BOA) was awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to the University of Missouri System's Kansas City campus. The BOA has an ultimate completion date of April 6, 2035 and was awarded on April 7, 2025, with no specified ceiling value. The purpose of this BOA appears to be to establish a contractual relationship for the provision of various products and services as requested through future task orders or via a price...
This Basic Ordering Agreement was awarded by the Bureau of Medicine and Surgery, a defense agency, to the University of Nebraska Medical Center (UNMC), a U.S. state government entity and educational institution. The contract has an ultimate completion date of August 25, 2034 and a ceiling value of $0.00, indicating it is a flexible contracting vehicle without a specific total contract value. The purpose of this IDV is to provide healthcare education and research services. UNMC has previously...
This is a multiple award Indefinite Delivery Contract (IDC) issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services. The contract has a ceiling value of $9,950,000 and was awarded to the University of Oklahoma (OU) to provide preclinical research and development services related to cancer prevention and treatment. The task orders issued under this IDC cover a range of preclinical oncology research activities, including the evaluation of...
The University of Washington has been awarded a Basic Ordering Agreement (BOA) by the Office of Naval Research, a defense agency, with a ceiling value of $50,000,000 over a period of performance ending on June 8, 2027. This single-award IDV contract will enable the University of Washington to provide a range of research and technical services to the federal government on an as-needed basis. Through this BOA, the University of Washington will leverage its extensive expertise in areas such as...
The Basic Ordering Agreement (BOA) was awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to The Washington University in St. Louis. This single-award IDV has an ultimate completion date of April 30, 2035 and does not have a specified ceiling value. The BOA provides a contractual mechanism for The Washington University, a leading private research institution, to execute a variety of specialized research and development services for the Defense agency....
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to OU Medicine Inc., a non-profit hospital in Oklahoma City, Oklahoma, for urgent and stat reference laboratory services. The BPA has a total ceiling value of $350,000.00 and a performance period through July 11, 2029. OU Medicine Inc. has been issued multiple BPA calls under this IDV, with task order values ranging from $21,705.83 to $119,432.95 and firm-fixed-price pricing. These BPA calls provide the...

The University of Oklahoma Health Sciences Center (OUHSC) was awarded a Basic Ordering Agreement (BOA) contract by the Bureau of Medicine and Surgery, a Defense agency, with a ceiling value of $0.00. This single-award IDV contract has an ultimate completion date of April 30, 2035.

Under this BOA, OUHSC provides a wide range of biomedical research, healthcare, scientific services, and educational programs to multiple federal agencies, including the Department of Veterans Affairs, U.S. Attorney's Offices, Department of the Navy, and National Cancer Institute. The contracted services have encompassed expert witness services, medical equipment procurement, radiopharmaceutical delivery, sequencing services, geriatric quality improvement coaching, and tuition reimbursement programs. Additionally, OUHSC holds an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Cancer Institute for the PREVENT Cancer Preclinical Drug Development Program, valued at approximately $149,995,000, to support preclinical drug development research, including evaluating efficacy and pharmacodynamic biomarkers for potential cancer preventive agents.

Generated 7/27/25, 12:51 AM